Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

Overscreening and overtreatment of men with prostate cancer and limited life expectancy continue to be an ongoing issue in the era of active surveillance.

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Nov. 16—c ― Dean Festa got lucky when he sought to make a change in his life insurance policy. His insurance agent told him he'd first have to be screened for prostate cancer, which would require him ...

Thumbs down for Roundup. Shocking research has revealed that more than a dozen chemicals used in popular weed killers like ...

Discover a recent study that revealed that patients treated for prostate cancer, particularly with radiotherapy, have an ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

Prostate cancer is a growing problem in men, and advanced cases are rising for the first time in 20 years, which is why ...

Tattoos can help radiation therapists with positioning but are a ... Others, including men with prostate cancer, have ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...